Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4651 USD | +6.97% | +51.37% | +52.10% |
May. 15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
May. 14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.10% | 43.73M | |
+32.68% | 50.85B | |
+0.13% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.38% | 26.11B | |
-22.13% | 19.13B | |
+8.45% | 13.05B | |
+27.25% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q3 2020 Earnings Call, Nov 12, 2020